Antelope Sharp shares: Fentanyl Patch project settled

     Sina Tip: This article belongs to a stock comment column, only for securities consultants on the relevant stocks or plates of personal views and analysis, and informal news reports, Sina does not guarantee its authenticity and objectivity, investors operate on this basis, risk from the bear.　　For accurate information about the unit, please refer to the Bulletin of the Shanghai and Shenzhen Stock Exchange. Darbond Securities Huhai Fentanyl patch is a synthetic potent anesthetic analgesic, its analgesic effect of 80 times times the morphine, known as the creation of a new era of cancer pain relief, is the safest international safety patch, the early varieties of all dependent on foreign imports, and China's largest fentanyl patch project settled in Henan Antelope Sharp. Fentanyl (skeleton type) of transdermal drug delivery technology, compared with the same type of analgesics have a reliable efficacy, safety and better, side effects of filial piety half-life long, the use of easy to carry and other obvious advantages. The fentanyl (skeleton type) Pastes is the National Special Management Medicine, the National access management is very strict, the access enterprise's technology, the management level request is high, obtains the project the establishment, means has obtained the huge potential city to produce 50 million to be used to be the fentanyl (skeleton type) project, Xinyang is one of the ten key projects under construction in 2009. The project has a total investment of nearly 200 million yuan, according to the development of antelope sharp requirements, through the introduction, digestion of the German lake of Wacker mature skeleton fentanyl transdermal patch technology and German Han-hui's fentanyl transdermal patch Special equipment, build an independent fentanyl patch production base to produce the international most advanced fentanyl patch (skeleton type) In order to further enhance the Antelope sharp independent innovation ability, and continuously improve China's transdermal patch development and production technology. Preliminary estimate, the project is completed and put into production, can realize the annual output value of 1 billion yuan, annual profits tax 200 million yuan, will provide the world's advanced fentanyl (skeleton type) SMD, further improve market product quality, reduce market prices, meet the clinical needs of doctors and patients, create more significant economic benefits,　　The establishment of a synchronized with the world's transdermal delivery technology platform, at the same time to promote the Antelope sharp "two pioneering" project smooth implementation, especially the Antelope sharp pharmaceutical production and management of new steps and local economic and social development plays an important role. The company is the National Torch plan key High-tech Enterprises, all product dosage forms and their production workshop through the national GMP certification, the current core business in the performance of the largest contribution to the paste products, the company's product for the Tongluo pain Cream (bone hyperplasia a stick), strong bone musk pain cream, The company strives to bring the antelope sharp into the first brand of Chinese plaster by 2010. 08 first half of the company selected national poverty alleviation leading enterprises, among the first "China Science and technology brand 500", "Antelope Sharp" selected "China's most valuable trademark" brand list, antelope Rui Zhuang bone musk pain Cream Rong Deng "China drug brand list" and so on, have further enhanced the corporate brand awareness and reputation. The company's rubber paste products market share of 20%, in the guarantee of the market position of hard paste products on the basis of the Antelope Rui Xinyang Science and Technology Park has been built into domesticFirst-class large-scale internal medicine base, will become the company's future profit growth point. Companies adhere to the modernization of traditional Chinese medicine road, put forward the product research and development policy of "production generation, reserve generation, development generation", 5-8% of sales revenue every year as a special fund for scientific research, fully invested in technological innovation and scientific research and development, established Provincial Technical center, and trained high-quality scientific research team, and Beijing Chemical Engineering University, Chinese Academy of Traditional Chinese Medicine Institute of Medicine in Beijing Zhongguancun set up Beijing Antelope Rui Albert Technology Co., Ltd. (Beijing High-tech Enterprises), set up their own scientific research base. The company concentrates the technical strength, enlarges the technical innovation strength, the first rubber ointment CO2 laser Ultra micro-hole technology, the domestic leading; a variety of dosage forms of drug production technology to achieve domestic first-class level, forming a large-scale production capacity. Companies to develop a variety of drugs, the formation of their own proprietary intellectual property rights.　　The company has set up post-doctoral research workstations, strengthened with institutions of higher learning, scientific research institutions, foreign well-known enterprises, and strive to build China's excellent pharmaceutical enterprises and the first brand of Chinese plaster, among the world's transdermal absorption of drug production enterprises in the advanced ranks. Fentanyl transdermal patch for narcotic drugs, is a national special management drugs, the state access management is very strict (the same product strictly controlled in 1~3 home). Access to the enterprise technology, management level requirements are very high, to obtain the project, means that access to a huge potential market, will be the driver of performance growth. China Central Television economic channel also interviewed on the Fentanyl Transdermal Patch project chairman of the Chonwey, Henan Daily, Dahe, Xinyang daily, Xinyang TV and other media also sent reporters to participate in the Antelope Rui Pharmaceutical annual output of 50 million paste fentanyl (skeleton type) Patch Project Foundation ceremony.